RECOVERY: Preclinical Toxicology and Pharmacology of Drugs Developed for Cancer, AIDS, and AIDS-Related Research

Contract HHSN261200422003C, titled "Preclinical Toxicology and Pharmacology of Drugs Developed for Cancer, AIDS, and AIDS-Related Research," has undergone a modification to incorporate funding from the American Recovery and Reinvestment Act (ARRA). This adjustment supports the research project focused on "In Vivo Screening of Combinations of Drugs to Treat Cancer." Due to the nature of the project, which lacks detailed Statement of Work specifications and presents challenges in cost estimation, the contract is not structured as a fixed-price agreement. The funding and project aim to enhance preclinical investigations into drug combinations that may improve cancer treatment outcomes. The awardee associated with this contract is identified by the DUNS number 009232752. The contract is linked to NAICS code 541711, which pertains to research and development in biotechnology. Key points of contact include Contracting Officer Stanley A. Knight and Contracting Officer/Team Leader MaryAnne M. Golling, who can provide further information or clarification. The contract was posted on September 7, 2010, and is managed by government officials accessible via the provided contact details.